(Q46920621)

26 December 2017

title

Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats (English)

1 reference

26 December 2017

main subject

pulmonary hypertension

1 reference

3

1 reference

26 December 2017

author name string

Hiroaki Obata

1

1 reference

26 December 2017

Yoshiki Sakai

2

1 reference

26 December 2017

Satoshi Takeshita

4

1 reference

26 December 2017

Hidezo Mori

5

1 reference

26 December 2017

Makoto Kodama

6

1 reference

26 December 2017

Kenji Kangawa

7

1 reference

26 December 2017

Yoshifusa Aizawa

8

1 reference

26 December 2017

Noritoshi Nagaya

9

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

26 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

26 December 2017

volume

177

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

195-201

1 reference

26 December 2017

Pulmonary Arterial Hypertension

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Prostanoid therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

A Fail-safe Mechanism for Negative Selection of Isotype-switched B Cell Precursors Is Regulated by the Fas/FasL Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Local delivery of IL-1 alpha polymeric microspheres for the immunotherapy of an experimental fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Macrophage activation for the production of immunostimulatory cytokines by delivering interleukin 1 via biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Pulsed controlled-released system for potential use in vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo: role of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Inhibition by cAMP of Ras-dependent activation of Raf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Prostaglandin Endoperoxides. A New Concept Concerning the Mode of Action and Release of Prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Thromboxane A2: effects on airway and vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Thromboxane A 2 and Vascular Smooth Muscle Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

Thromboxane synthetase inhibition in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200703-349OC

10.1164/RCCM.200703-349OC

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017